
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Articles tagged with Sales Force from Medical Marketing and Media</title>
        <link>http://www.mmm-online.com/sales-force/topic/229/</link>
        <description>Articles tagged with Sales Force from Medical Marketing and Media</description>
        <itunes:author>MMM</itunes:author>
        <itunes:subtitle></itunes:subtitle>
        <itunes:summary></itunes:summary>
        <itunes:owner>
            <itunes:name></itunes:name>
            <itunes:email>mmmsubs@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/32/MMM_logo_28402_31022.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>With iPad push, Merck gets global right</title>
          <description>Merck came late to the iPad party, but the company has made up the distance by releasing a global template for details using the device.</description>
          <link>http://www.mmm-online.com/with-ipad-push-merck-gets-global-right/article/295046/</link>
          <pubDate>Mon, 27 May 2013 19:54:45 GMT</pubDate>
          <itunes:summary>Merck came late to the iPad party, but the company has made up the distance by releasing a global template for details using the device.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Purdue puts Intermezzo DTC to bed</title>
          <description>Marketing partner Transcept pulled 90 sales reps and Purdue closed out the majority of its DTC outreach in March.</description>
          <link>http://www.mmm-online.com/purdue-puts-intermezzo-dtc-to-bed/article/293546/</link>
          <pubDate>Thu, 16 May 2013 20:36:00 GMT</pubDate>
          <itunes:summary>Marketing partner Transcept pulled 90 sales reps and Purdue closed out the majority of its DTC outreach in March.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Business briefs: Baxter; Eli Lilly; CDHPs and Statins</title>
          <description>Baxter&apos;s Alzheimer&apos;s treatment is out of the running; Eli Lilly has upped its layoffs; insured consumers are spending less on healthcare; stains and prostate cancer may have an amicable relationship; doctors aren&apos;t screening teens for HIV.</description>
          <link>http://www.mmm-online.com/business-briefs-baxter-eli-lilly-cdhps-and-statins/article/292338/</link>
          <pubDate>Tue, 07 May 2013 16:42:12 GMT</pubDate>
          <itunes:summary>Baxter&apos;s Alzheimer&apos;s treatment is out of the running; Eli Lilly has upped its layoffs; insured consumers are spending less on healthcare; stains and prostate cancer may have an amicable relationship; doctors aren&apos;t screening teens for HIV.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>E-details soar as pharmas slash sales forces</title>
          <description>Pharmas spent 40% more on non-personal promotion to healthcare professionals globally last year while continuing to shed sales reps, a Cegedim survey shows.</description>
          <link>http://www.mmm-online.com/e-details-soar-as-pharmas-slash-sales-forces/article/291727/</link>
          <pubDate>Thu, 02 May 2013 16:41:48 GMT</pubDate>
          <itunes:summary>Pharmas spent 40% more on non-personal promotion to healthcare professionals globally last year while continuing to shed sales reps, a Cegedim survey shows.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Duchesnay returns morning sickness drug to US market</title>
          <description>The first drug for morning sickness in thirty years enters the market this month.</description>
          <link>http://www.mmm-online.com/duchesnay-returns-morning-sickness-drug-to-us-market/article/291376/</link>
          <pubDate>Wed, 01 May 2013 16:12:39 GMT</pubDate>
          <itunes:summary>The first drug for morning sickness in thirty years enters the market this month.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Breakup, Xeljanz plans dominate Pfizer earnings call</title>
          <description>Sales slipped 9% during the quarter, compared to the same period last year, but analysts zeroed in on if and when the company will split and how arthritis pill Xeljanz will tackle Europe.</description>
          <link>http://www.mmm-online.com/breakup-xeljanz-plans-dominate-pfizer-earnings-call/article/291220/</link>
          <pubDate>Tue, 30 Apr 2013 16:32:13 GMT</pubDate>
          <itunes:summary>Sales slipped 9% during the quarter, compared to the same period last year, but analysts zeroed in on if and when the company will split and how arthritis pill Xeljanz will tackle Europe.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>After rough &apos;12, PHCG looks to inject more life into business</title>
          <description>An agency bellwether, PHCG is hoping to return to growth after a tame 2012, its CEO said this week.</description>
          <link>http://www.mmm-online.com/after-rough-12-phcg-looks-to-inject-more-life-into-business/article/290582/</link>
          <pubDate>Thu, 25 Apr 2013 18:50:41 GMT</pubDate>
          <itunes:summary>An agency bellwether, PHCG is hoping to return to growth after a tame 2012, its CEO said this week.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Higher prices keep Lilly&apos;s quarter flat; Cymbalta DTC pull-back planned</title>
          <description>Lilly said sales-force downsizing was the right move considering the current portfolio mix and generics shadow. Management also teased some vague pipeline details.</description>
          <link>http://www.mmm-online.com/higher-prices-keep-lillys-quarter-flat-cymbalta-dtc-pull-back-planned/article/290304/</link>
          <pubDate>Wed, 24 Apr 2013 15:56:23 GMT</pubDate>
          <itunes:summary>Lilly said sales-force downsizing was the right move considering the current portfolio mix and generics shadow. Management also teased some vague pipeline details.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Analysts on Qsymia: show me the payers</title>
          <description>Analysts write expanded Qsymia distribution will do little to boost sales if payers are not on board.</description>
          <link>http://www.mmm-online.com/analysts-on-qsymia-show-me-the-payers/article/289207/</link>
          <pubDate>Wed, 17 Apr 2013 16:02:11 GMT</pubDate>
          <itunes:summary>Analysts write expanded Qsymia distribution will do little to boost sales if payers are not on board.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Business briefs: AbbVie cuts sales staff; docs say patients share health data; Stonefly founder dies</title>
          <description>AbbVie slashes sales jobs</description>
          <link>http://www.mmm-online.com/business-briefs-abbvie-cuts-sales-staff-docs-say-patients-share-health-data-stonefly-founder-dies/article/289106/</link>
          <pubDate>Tue, 16 Apr 2013 17:17:54 GMT</pubDate>
          <itunes:summary>AbbVie slashes sales jobs</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  